135 related articles for article (PubMed ID: 37960847)
21. Case Report: Necrotizing Erythema Nodosum as a Manifestation of Lepromatous Leprosy Relapse 50 Years after the Initial Infection.
Galeano J; Contreras A; Pabón L; Ruiz AC; Serrano-Coll H; Arboleda M
Am J Trop Med Hyg; 2023 Jul; 109(1):53-56. PubMed ID: 37253443
[TBL] [Abstract][Full Text] [Related]
22. [Chemotherapy-induced erythema nodosum leprosum: successful treatment with thalidomide].
Petering H; Kiehl P; Vogelbruch M; Sticht-Groh V; Kapp A; Werfel T
Hautarzt; 2001 Oct; 52(10 Pt 2):966-9. PubMed ID: 11715395
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of erythema nodosum leprosum with apremilast.
Abril-Pérez C; Palacios-Diaz RD; Navarro-Mira MÁ; Botella-Estrada R
Dermatol Ther; 2022 Mar; 35(3):e15258. PubMed ID: 34890096
[No Abstract] [Full Text] [Related]
24. [Review: update on erythema nodosum leprosum].
Morand JJ; Badiane C; Bobin P
Med Trop (Mars); 2004; 64(5):423-30. PubMed ID: 15771008
[TBL] [Abstract][Full Text] [Related]
25. Lepromatous leprosy in Saudi female from central region.
al-Majed S
J Hyg Epidemiol Microbiol Immunol; 1991; 35(2):163-6. PubMed ID: 1940331
[TBL] [Abstract][Full Text] [Related]
26. [Treatment of erythema nodosum leprosum using thalidomide].
Sheskin J
Acta Leprol; 1983; 1(1):41-50. PubMed ID: 6401140
[No Abstract] [Full Text] [Related]
27. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition.
Costa PDSS; Fraga LR; Kowalski TW; Daxbacher ELR; Schuler-Faccini L; Vianna FSL
Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830
[TBL] [Abstract][Full Text] [Related]
28. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
Vetrichevvel TP; Pise GA; Thappa DM
Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
[TBL] [Abstract][Full Text] [Related]
29. [Leprosy and the testis].
Rodríguez G; Abaúnza MC; Vargas EJ; López F
Biomedica; 2012; 32(1):13-22. PubMed ID: 23235783
[TBL] [Abstract][Full Text] [Related]
30. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
[TBL] [Abstract][Full Text] [Related]
31. Recurrent erythema nodosum leprosum leading to secondary renal amyloidosis and nephrotic syndrome in an Indian patient with lepromatous leprosy.
Ahuja R; Garg S; Barwad A; Subbiah A; Gupta V
Int J Dermatol; 2023 Sep; 62(9):e514-e517. PubMed ID: 37066445
[No Abstract] [Full Text] [Related]
32. Leukemoid reaction in erythema nodosum leprosum in a leprosy patient.
Chaudhary SD; Sen R; Jain VK; Dixit VB
Indian J Lepr; 1988 Oct; 60(4):572-6. PubMed ID: 3253336
[TBL] [Abstract][Full Text] [Related]
33. Chronic recalcitrant erythema nodosum leprosum: therapeutic dilemma and role of mycobacterium indicus pranii vaccine.
Gupta SK; Kumari S
An Bras Dermatol; 2022; 97(1):49-53. PubMed ID: 34848113
[TBL] [Abstract][Full Text] [Related]
34. Venous thrombo-embolism: thalidomide and leprosy.
Chhabria BA; Pannu AK; Bhalla A
QJM; 2017 Jun; 110(6):383-384. PubMed ID: 28340061
[No Abstract] [Full Text] [Related]
35. Experiences with Thalidomide for Erythema Nodosum Leprosum– a retrospective study.
Darlong J; Govindharaj P; Charles DE; Menzies A; Mani S
Lepr Rev; 2016 Jun; 87(2):211-20. PubMed ID: 30212168
[TBL] [Abstract][Full Text] [Related]
36. Erythema nodosum leprosum necroticans in a child--an unusual manifestation.
Pandhi D; Mehta S; Agrawal S; Singal A
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):122-6. PubMed ID: 16830655
[TBL] [Abstract][Full Text] [Related]
37. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
[TBL] [Abstract][Full Text] [Related]
38. [Late diagnosis nodular lepromatous leprosy from the Peruvian Amazon, with development of a type 2 reaction].
Villegas-Chiroque M; Maldonado-Gómez W; Espino-Saavedra W; Ventura-Flores R
Rev Chilena Infectol; 2021 Oct; 38(5):707-712. PubMed ID: 35506839
[TBL] [Abstract][Full Text] [Related]
39. Subcutaneous lepromas as leprosy-type presentation.
Alvarez-Ruiz SB; Delgado-Jiménez Y; Aragüés M; Fraga J; García-Díez A
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):344-5. PubMed ID: 16503904
[No Abstract] [Full Text] [Related]
40. Recognizing and managing the immunologic reactions in leprosy.
Kamath S; Vaccaro SA; Rea TH; Ochoa MT
J Am Acad Dermatol; 2014 Oct; 71(4):795-803. PubMed ID: 24767732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
